Zielinski, Robert R., Arun A. Azad, Kim N. Chi, and Scott Tyldesley. “Population-Based Impact on Overall Survival After the Introduction of Docetaxel As Standard Therapy for Metastatic Castration Resistant Prostate Cancer”. Canadian Urological Association Journal 8, no. 7-8 (August 11, 2014): e520–3. Accessed April 25, 2024. https://cuaj.ca/index.php/journal/article/view/2076.